IBDEI0EP ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7071,1,4,0)
 ;;=4^374.50
 ;;^UTILITY(U,$J,358.3,7071,2)
 ;;=^269106
 ;;^UTILITY(U,$J,358.3,7072,0)
 ;;=374.52^^49^553^34
 ;;^UTILITY(U,$J,358.3,7072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7072,1,3,0)
 ;;=3^Eyelid Hyperpigmentation
 ;;^UTILITY(U,$J,358.3,7072,1,4,0)
 ;;=4^374.52
 ;;^UTILITY(U,$J,358.3,7072,2)
 ;;=^269108
 ;;^UTILITY(U,$J,358.3,7073,0)
 ;;=374.53^^49^553^36
 ;;^UTILITY(U,$J,358.3,7073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7073,1,3,0)
 ;;=3^Eyelid Hypopigmentation
 ;;^UTILITY(U,$J,358.3,7073,1,4,0)
 ;;=4^374.53
 ;;^UTILITY(U,$J,358.3,7073,2)
 ;;=^269109
 ;;^UTILITY(U,$J,358.3,7074,0)
 ;;=374.54^^49^553^35
 ;;^UTILITY(U,$J,358.3,7074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7074,1,3,0)
 ;;=3^Eyelid Hypertrichosis
 ;;^UTILITY(U,$J,358.3,7074,1,4,0)
 ;;=4^374.54
 ;;^UTILITY(U,$J,358.3,7074,2)
 ;;=^269111
 ;;^UTILITY(U,$J,358.3,7075,0)
 ;;=374.56^^49^553^39
 ;;^UTILITY(U,$J,358.3,7075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7075,1,3,0)
 ;;=3^Eyelid Oth Degenerative Skin D/O
 ;;^UTILITY(U,$J,358.3,7075,1,4,0)
 ;;=4^374.56
 ;;^UTILITY(U,$J,358.3,7075,2)
 ;;=^269114
 ;;^UTILITY(U,$J,358.3,7076,0)
 ;;=374.81^^49^553^33
 ;;^UTILITY(U,$J,358.3,7076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7076,1,3,0)
 ;;=3^Eyelid Hemorrhage
 ;;^UTILITY(U,$J,358.3,7076,1,4,0)
 ;;=4^374.81
 ;;^UTILITY(U,$J,358.3,7076,2)
 ;;=^269115
 ;;^UTILITY(U,$J,358.3,7077,0)
 ;;=374.82^^49^553^32
 ;;^UTILITY(U,$J,358.3,7077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7077,1,3,0)
 ;;=3^Eyelid Edema
 ;;^UTILITY(U,$J,358.3,7077,1,4,0)
 ;;=4^374.82
 ;;^UTILITY(U,$J,358.3,7077,2)
 ;;=^276852
 ;;^UTILITY(U,$J,358.3,7078,0)
 ;;=374.85^^49^553^45
 ;;^UTILITY(U,$J,358.3,7078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7078,1,3,0)
 ;;=3^Eyelid Vascular Anomalies
 ;;^UTILITY(U,$J,358.3,7078,1,4,0)
 ;;=4^374.85
 ;;^UTILITY(U,$J,358.3,7078,2)
 ;;=^269120
 ;;^UTILITY(U,$J,358.3,7079,0)
 ;;=374.86^^49^553^38
 ;;^UTILITY(U,$J,358.3,7079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7079,1,3,0)
 ;;=3^Eyelid Oth D/O,Floppy Eyelid Synd
 ;;^UTILITY(U,$J,358.3,7079,1,4,0)
 ;;=4^374.86
 ;;^UTILITY(U,$J,358.3,7079,2)
 ;;=^269121
 ;;^UTILITY(U,$J,358.3,7080,0)
 ;;=376.11^^49^553^89
 ;;^UTILITY(U,$J,358.3,7080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7080,1,3,0)
 ;;=3^Orbit Granuloma/Pseudotumor
 ;;^UTILITY(U,$J,358.3,7080,1,4,0)
 ;;=4^376.11
 ;;^UTILITY(U,$J,358.3,7080,2)
 ;;=^269176
 ;;^UTILITY(U,$J,358.3,7081,0)
 ;;=376.21^^49^553^93
 ;;^UTILITY(U,$J,358.3,7081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7081,1,3,0)
 ;;=3^Orbit Thyrotoxic Exophthalmos
 ;;^UTILITY(U,$J,358.3,7081,1,4,0)
 ;;=4^376.21
 ;;^UTILITY(U,$J,358.3,7081,2)
 ;;=^269181
 ;;^UTILITY(U,$J,358.3,7082,0)
 ;;=376.33^^49^553^83
 ;;^UTILITY(U,$J,358.3,7082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7082,1,3,0)
 ;;=3^Orbit Edema
 ;;^UTILITY(U,$J,358.3,7082,1,4,0)
 ;;=4^376.33
 ;;^UTILITY(U,$J,358.3,7082,2)
 ;;=^269186
 ;;^UTILITY(U,$J,358.3,7083,0)
 ;;=376.40^^49^553^82
 ;;^UTILITY(U,$J,358.3,7083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7083,1,3,0)
 ;;=3^Orbit Deformity,Unspec
 ;;^UTILITY(U,$J,358.3,7083,1,4,0)
 ;;=4^376.40
 ;;^UTILITY(U,$J,358.3,7083,2)
 ;;=^269191
 ;;^UTILITY(U,$J,358.3,7084,0)
 ;;=376.41^^49^553^90
 ;;^UTILITY(U,$J,358.3,7084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7084,1,3,0)
 ;;=3^Orbit Hypertelorism
 ;;^UTILITY(U,$J,358.3,7084,1,4,0)
 ;;=4^376.41
 ;;^UTILITY(U,$J,358.3,7084,2)
 ;;=^269192
 ;;^UTILITY(U,$J,358.3,7085,0)
 ;;=376.43^^49^553^81
 ;;^UTILITY(U,$J,358.3,7085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7085,1,3,0)
 ;;=3^Orbit Deformity d/t Bone Disease
